Drug & supplement interaction

Tetrahydrocannabivarin (thcv) + Encorafenib

Encorafenib brand name: Braftovi.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Tetrahydrocannabivarin (thcv) and Encorafenib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Tetrahydrocannabivarin (thcv) and Encorafenib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Encorafenib and Tetrahydrocannabivarin (thcv) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Tetrahydrocannabivarin (thcv) at all — not against Encorafenib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Tetrahydrocannabivarin (thcv) safety at a glance

Tetrahydrocannabiv... overall Use caution Human safety data are limited, and product quality and legality vary a lot.
Pregnancy Avoid Cannabis-derived compounds are not considered safe in pregnancy.
Breastfeeding Avoid Cannabinoids can pass into breast milk, so avoid use while nursing.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Encorafenib and Tetrahydrocannabivarin (thcv)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Encorafenib’s Own FDA Label Lists

This is not an interaction — none of it involves Tetrahydrocannabivarin (thcv). These are the most notable effects listed in the ADVERSE REACTIONS section of Encorafenib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • A bowel blockage Worth acting on
  • Muscle weakness Worth acting on
  • Unsteadiness Worth acting on
  • A heart attack Worth acting on
  • Heart failure Worth acting on
  • An irregular heartbeat Worth acting on
  • Chest pain Worth acting on
  • Kidney problems Worth acting on
  • Anemia Worth acting on
  • Raised blood pressure Worth acting on

Showing the 10 most notable of 43 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Encorafenib. Read the label on DailyMed › Tetrahydrocannabivarin (thcv)’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Tetrahydrocannabivarin (thcv) side to compare — that is a limit of the record, not a statement that Tetrahydrocannabivarin (thcv) has no side effects.

Everything else you take

See Every Supplement That Interacts With Encorafenib

This page covers Tetrahydrocannabivarin (thcv) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Encorafenib page lists 151 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), American Hellebore (major), Arsenic (major), Cesium (major) and Ephedra (major).

By severity: 8 major · 104 moderate · 39 minor.

From our pharmacist’s overview on the Encorafenib page

“Grapefruit is the first thing I would take off the table for anyone on encorafenib (Braftovi), a targeted cancer medicine, because it blocks the enzyme (CYP3A4) that clears the drug, pushing levels and side effects higher. St.”

Reviewed by 2 · Jul 18, 2026

Open the Encorafenib interaction page

How much people look this up

Where Tetrahydrocannabivarin (thcv) and Encorafenib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Tetrahydrocannabivarin (thcv)
Steady interest

#877 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Encorafenib
Steady interest

#1,761 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Tetrahydrocannabivarin (thcv) is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Tetrahydrocannabivarin (thcv) reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 20, 2026. The Tetrahydrocannabivarin (thcv) and Encorafenib records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Tetrahydrocannabivarin (thcv)

What is Tetrahydrocannabivarin (thcv)?

  • Appetite control and weight management
  • Blood sugar support
  • Energy and focus
  • General wellness

Tetrahydrocannabivarin (THCV) is a minor cannabinoid found in cannabis that is being studied for appetite, metabolism, and blood sugar, but human evidence is very limited. Product quality, legal status, and dosing vary widely, so talk with your pharmacist or doctor before trying it, and avoid it during pregnancy and breastfeeding.

Cannabis sativa · Cannabaceae · Flowers and leaves of the cannabis plant (THCV is an extracted or isolated cannabinoid) · Oils, tinctures, capsules, gummies, vape products, and isolated extracts

An interaction check asks whether these two react with each other — it does not ask whether Tetrahydrocannabivarin (thcv) is a good idea for someone in your situation. Here is what our Tetrahydrocannabivarin (thcv) record says about it on its own.

Tetrahydrocannabivarin (thcv): dosing

There is no established standard dose for THCV. Research is too limited to recommend a specific milligram amount, and effects may even differ between low and high doses.If you choose to try a product, follow the directions on the label and start with the lowest amount.

From our Tetrahydrocannabivarin (thcv) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Tetrahydrocannabivarin (thcv) monograph & all interactions
Medication

About Encorafenib

What Is Encorafenib Used For?

Brand name: Braftovi

Braftovi is used to treat cancers that have a specific change (mutation) in a gene called BRAF — specifically the V600E or V600K mutation, which must be confirmed by an FDA-authorized test before starting treatment. It is always used in combination with other medicines, never alone as standard therapy.

Braftovi (in combination with binimetinib) treats unresectable or metastatic melanoma with a BRAF V600E or V600K mutation. For metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, Braftovi is used either with cetuximab and fluorouracil-based chemotherapy, or with cetuximab alone after prior therapy. Braftovi (in combination with binimetinib) also treats metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation.

Most-Reported Side Effects for Encorafenib

From FAERS, the FDA’s public side-effect reporting system (0 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Nausea 842 reports
Fatigue 770 reports
Diarrhea 634 reports
Fever 599 reports
Neoplasm progression 552 reports
See full Encorafenib drug information
Keep checking

Other Drugs & Tetrahydrocannabivarin (thcv)

Browse every other medication we’ve checked against Tetrahydrocannabivarin (thcv) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Tetrahydrocannabivarin (thcv) References

The 2 sources that drive our Tetrahydrocannabivarin (thcv) monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Tetrahydrocannabivarin (thcv) is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Cannabis (Marijuana) and Cannabinoids: What You Need To Know — NIH NCCIH Source
  2. Marijuana — MedlinePlus Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Tetrahydrocannabivarin (thcv) and Encorafenib Together: Common Questions

Is it safe to take Tetrahydrocannabivarin (thcv) with Encorafenib?
We do not list a known interaction between Tetrahydrocannabivarin (thcv) and Encorafenib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Encorafenib interact with any supplements?
Yes. Encorafenib has documented interactions with 151 supplements in our database — Tetrahydrocannabivarin (thcv) is not one of them. The Encorafenib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Encorafenib and Tetrahydrocannabivarin (thcv)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.